Fund details
Supports entrepreneurs leveraging Deep Tech to address challenges, amplifying the positive impact of capitalism while cutting its costs.
Go to profile
Partners related to this fund
Funds with similar target sectors
View all funds
Dr. Kiersten Stead
Managing Partner
Kiersten Stead is a Managing Partner at DCVC Bio, focusing on investments in life sciences and biotechnology. She serves on Genome Canada's investment committee and holds degrees from the University of Calgary and the University of Alberta. Kiersten's work focuses on leveraging science to improve healthcare outcomes.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Target regions
Africa
USA
Investment ranges
$3M - $10M
Focus areas
Biotech
Deeptech
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.
Related Sector Funds
Funds investing in similar sectors.
.svg)
